Paricalcitol Injection
Product Images NDC 70121-1035

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Paricalcitol (NDC 70121-1035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Paricalcitol Injection 1)

FDA Label Image

2 (Paricalcitol Injection 2)

Paricalcitol Injection, USP is a medication administered through intravenous use. It comes as a single dose vial that contains 2 mcg/mL of paricalcitol, along with propylene glycol (30% v/v) and alcohol (20% v/v). The unused portion must be discarded after use. This medication is manufactured in India and distributed by Amneal Pharmaceutical LLC. The provided text includes necessary details such as the license number, manufacturer's location, and lot number. The medication is available only by prescription.*

FDA Label Image

3 (Paricalcitol Injection 3)

This appears to be a product label for Paricalcitol Injection, USP. It is a sterile, non-pyrogenic solution for intravenous use, containing lcitol, USP. The label provides instructions for use and dosage recommendations, as well as storage conditions. It also mentions that unused portions should be discarded and provides product identification numbers.*

FDA Label Image

4 (Paricalcitol Injection 4)

FDA Label Image

5 (Paricalcitol Injection 5)

This is a product description for Paricalcitol Injection, which comes in 10 x 1mL single-dose vials containing Paracalcitol USP at 5mg. It also contains propylene glycol and alcohol. It should be stored in a controlled room temperature of 20 to 25°C. It should be used intravenously and sterile techniques must be used. Any unused portion must be discarded. Full prescribing information can be found in the package insert. The NDC number is 7012110347.*

FDA Label Image

6 (Paricalcitol Injection 6)

Paricalcitol Injection, USP is a medication available in a single-dose vial form for intravenous use. Each 2 mL of this medication contains 10 mcg/2 mL (5 meg/mL) of paricalcitol, USP, 5 mcg propylene glycol (30% v/v), and 20% alcohol (v/v). It is manufactured in India under Mfg. Lic. No. G/29/7772 and distributed by Amneal Pharmaceuticals LLC. Any unused portion of the medication should be discarded, and it is only available through prescription.*

FDA Label Image

7 (Paricalcitol Injection 7)

FDA Label Image

8 (Paricalcitol Injection 8)

This is a description of Paricalcitol Injection, USP, which is a medication for IV use. It comes in a multi-dose vial, with each mL of the solution containing 5mg of paricalcitol. The solution also contains propylene glycol (30%) and alcohol (20%). It is manufactured in India and is distributed by Amneal Pharmaceuticals. The lot number is Brogenater, NJ 08307, and the expiration date is May 2019.*

FDA Label Image

9 (Paricalcitol Injection 9)

Paricalcitol Injection, USP is a sterile, non-pyrogenic solution used for intravenous use. Each 2 mL of the solution contains 10 meg of Paricalcitol. It is supplied in multi-dose vials of 10x2mL and can be used up to 7 days after the initial vial use while stored at a controlled room temperature. The vials should be covered and cleansed after each use, and stored with an epic.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.